BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Bone Biologics Gets Approval for Pilot Clinical Trial with NB1 for Spinal Fusion in Australia.

Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that the Human Research Ethics Committ...

April 13, 2023 | News

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

The range of oral dosage form products will be manufactured at Bora’s Zhunan Site, which is one of the largest US FDA and MHRA-approved pharmaceutica...

April 10, 2023 | News

Catalent builds $20M expansion for German clinical supply facility

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of ...

April 06, 2023 | News

WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System

WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), announces that it has added two 2,000 L reactors and a lar...

April 06, 2023 | News

Bridgewest Group launches NovaCina, new sterile injectable CDMO

The newly acquired facility and team is in Bentley, a suburb of Perth in Western Australia. It will operate as a Contract Development and Ma...

April 05, 2023 | News

Suvoda Unveils New Brand to Reflect Expanded Focus in Complex Clinical Trial Management

Suvoda LLC in March month, launched a refreshed brand, to better reflect its leadership position as a global clinical trial technology company t...

April 04, 2023 | News

Cambrex Opens New Stability Storage Facility in Belgium

Strategically located in the Liège region and approximately 90 kilometers from Brussels, the new state-of-the-art temperature-controlled and mo...

April 04, 2023 | News

ABIONYX Pharma Unveils Ophthalmology Strategy and Positive Preclinical Results for Innovative Technologies.

Very promising preclinical results of the apoA-I biovector in an acute inflammation model Development of safe corticoids to limit traditional corticoid-...

April 01, 2023 | News

Evonik breaks ground on $220 million Lipid Innovation Center

Facility to secure global supply of functional excipients for RNA medicines Cooperative agreement with U.S. Government to advance U.S. biopharma industr...

March 30, 2023 | News

Remedium and Exothera partner on scale-up and demonstration runs for AAV2-FGF18

Remedium’s lead candidate is the only disease modifying gene therapy based on the clinically proven regenerative mechanism of FGF18. OA is the larges...

March 30, 2023 | News

Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards

▪ Vetter celebrates its second consecutive year earning this award in six categories with three additional honors in the CDMO Leadership Awards&nbs...

March 28, 2023 | News

YS Biopharma's PIKA COVID-19 Vaccine Shows Better Antibody Response Than Inactivated Vaccine in Phase II Study

The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inactivated COVID-19 vaccine, measured by GMT of neutralizing a...

March 28, 2023 | News

Enveric Biosciences Selects Australian CRO, Avance Clinical

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of nove...

March 27, 2023 | News

WuXi Biologics Reports Remarkable 2022 Annual Results

2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...

March 23, 2023 | News

Stay Connected